Equities Analysts Offer Predictions for ISRG Q3 Earnings

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Equities research analysts at Leerink Partnrs increased their Q3 2025 EPS estimates for Intuitive Surgical in a report released on Wednesday, July 23rd. Leerink Partnrs analyst M. Kratky now expects that the medical equipment provider will post earnings of $1.63 per share for the quarter, up from their prior forecast of $1.56. The consensus estimate for Intuitive Surgical’s current full-year earnings is $6.43 per share.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter in the previous year, the business posted $1.78 earnings per share. The business’s revenue was up 21.4% compared to the same quarter last year.

ISRG has been the topic of a number of other research reports. Piper Sandler reiterated an “overweight” rating and set a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a “hold” rating to a “sell” rating and lowered their target price for the company from $515.00 to $440.00 in a research note on Monday, June 9th. UBS Group boosted their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research note on Wednesday. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday. Finally, Royal Bank Of Canada boosted their target price on shares of Intuitive Surgical from $605.00 to $615.00 and gave the company an “outperform” rating in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $592.05.

Intuitive Surgical Stock Up 1.5%

ISRG stock opened at $495.86 on Friday. Intuitive Surgical has a twelve month low of $425.00 and a twelve month high of $616.00. The stock has a market capitalization of $177.73 billion, a price-to-earnings ratio of 69.16, a price-to-earnings-growth ratio of 5.45 and a beta of 1.64. The firm’s fifty day simple moving average is $529.86 and its two-hundred day simple moving average is $535.13.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds have recently modified their holdings of the stock. Chilton Capital Management LLC increased its holdings in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares in the last quarter. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $26,000. Global Financial Private Client LLC increased its holdings in shares of Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 38 shares in the last quarter. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical during the first quarter valued at about $26,000. Finally, Hurley Capital LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $28,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director directly owned 6,371 shares of the company’s stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 7,798 shares of company stock valued at $3,955,331. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.